Vizgen
PrivateLast Round
Series E
Jan 8, 2026
Total Funding Raised
$328.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Vizgen is a biotechnology company that provides spatially resolved, single-cell gene expression profiling tools to enhance understanding of biological systems and diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Imaging, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vizgen Comparables
Compare Vizgen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Resolve Biosciences | 84% | |
| Stellaromics | 83% | |
| 10x Genomics | 81% | |
Vizgen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Jan 8, 2026 | ||||
| Series D | Oct 9, 2024 | ||||
| Growth Equity | Mar 8, 2024 | ||||
| Series C | Jun 3, 2022 | ||||
| Series B | Jul 20, 2021 | ||||
Series B | Apr 7, 2021 |
Vizgen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ARCH Venture Partners | Series B, Series D, Series C, Series A, Series E |
| M Ventures | Series D, Series E |
| Northpond Ventures | Series C, Series D, Series B, Series A, Series E |
| ARCH Venture Partners | Series B, Series D, Series C, Series A, Series E |
| Blue Water Life Science Advisors | Series C |
| Novalis LifeSciences | Series C, Series B |
| Northpond Ventures | Series C, Series D, Growth Equity, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
$48M Series E round completed.
- Nov 17, 2025
Collaboration with Ultivue to serve big pharma customers and CROs.
Vizgen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vizgen's valuation, stock price, and market status.